SAB Biotherapeutics, Inc. (SABS) ownership: Top institutional holder: Vivo Capital, LLC ($43.74M). Insider activity: Net Seller (1 buys, 5 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Vivo Capital, LLC | 11420000.00 | $43.74M | 2026-03-31 |
| Caligan Partners LP | 7967207.00 | $30.51M | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 6431743.00 | $24.63M | 2026-03-31 |
| Commodore Capital LP | 4401500.00 | $16.86M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 4401500.00 | $16.86M | 2026-03-31 |
| Balyasny Asset Management L.P. | 3760439.00 | $14.40M | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3405553.00 | $13.04M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 3032697.00 | $11.62M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-03-24 | |
| Sell | null | 2026-02-03 | |
| Sell | null | 2026-02-03 | |
| Sell | null | 2026-02-03 | |
| Sell | null | 2026-02-03 | |
| Sell | null | 2026-02-03 |
Back to SABS overview · SABS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.